At the National Minimally Invasive Urological Surgery Congress held in Antalya, the latest innovations in diagnosis and treatment of prostate cancer, one of the most common cancers in men, were shared. In fact, a 'Robotic Biopsy Course' was even organized for training purposes for urology specialists and assistants.
TARGET-DIRECTED DEFINITIVE DIAGNOSIS
Vice President of the Minimally Invasive Urology Association, Urology Specialist Prof. Dr. Barbaros Başeskioğlu stated that prostate cancer can be treated successfully with early diagnosis and said: "For the diagnosis of prostate cancer, the blood test we call PSA, rectal examination and multiparametric MRI images have an important place. Prostate biopsy is performed for a definitive diagnosis. The standard is the rectal route." "The methods in which needles pass through the intestine have gradually begun to be abandoned. The biggest reason for this is bleeding in the anal area and the risk of serious infection that can cause death."
REDUCES THE RISK OF SEVERE INFECTION
Professor said that the methods in which the needles do not pass through the intestines, which are called perineal methods in the world, are now gradually being implemented in our country. Dr. Başeskioğlu said: "In the robotic method, multiple prostate biopsies can be taken from only two entry points. All biopsies can be taken from two entry points, one for the right lobe of the prostate and one for the left lobe. In this method, all biopsies can be taken by fusion with MRI images. "Targeted biopsy is performed. With this, prostate cancer foci that may be missed in standard methods can be sampled with higher accuracy. Having only two entry points significantly reduces the risk of bleeding, pain and infection after biopsy. At the same time, the prostate can be mapped with accuracy with robotic guidance."